Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 508

1.

Prostate-specific antigen screening among young men in the United States.

Scales CD Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW.

Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.

2.

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Ross LE, Berkowitz Z, Ekwueme DU.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709.

3.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
4.

Behavioral associations between prostate and colon cancer screening.

Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ.

J Am Coll Surg. 2005 Feb;200(2):216-23.

PMID:
15664097
5.

Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.

Whittemore AS, Cirillo PM, Feldman D, Cohn BA.

J Urol. 2005 Sep;174(3):872-6; discussion 876.

PMID:
16093978
6.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.

7.

Trends in prostate-specific antigen testing from 1995 through 2004.

Farwell WR, Linder JA, Jha AK.

Arch Intern Med. 2007 Dec 10;167(22):2497-502.

PMID:
18071173
8.

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

Etzioni R, Berry KM, Legler JM, Shaw P.

Urology. 2002 Feb;59(2):251-5.

PMID:
11834397
9.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
10.
12.

A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS.

Cancer. 2006 Feb 15;106(4):765-74.

13.

Relationship between body mass index and prostate cancer screening in the United States.

Scales CD Jr, Curtis LH, Norris RD, Schulman KA, Dahm P, Moul JW.

J Urol. 2007 Feb;177(2):493-8.

PMID:
17222617
14.

Racial differences in screening for prostate cancer in the elderly.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J.

Arch Intern Med. 2004 Sep 27;164(17):1858-64.

PMID:
15451760
15.

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.

Am J Med. 1998 Jun;104(6):517-25.

PMID:
9674713
16.

Prostate carcinoma knowledge, attitudes, and screening behavior among African-American men in Central Harlem, New York City.

Ashford AR, Albert SM, Hoke G, Cushman LF, Miller DS, Bassett M.

Cancer. 2001 Jan 1;91(1):164-72.

PMID:
11148573
17.
18.

Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.

McDavid K, Melnik TA, Derderian H.

Prev Med. 2000 Sep;31(3):195-202.

PMID:
10964632
19.

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.

Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D.

Prev Med. 2004 Jun;38(6):732-44.

PMID:
15193893
20.

Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.

Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL.

Urology. 2006 Jul;68(1):89-93.

PMID:
16844451

Supplemental Content

Support Center